RYNZN you mention a bidding war between Sarepta and Pfizer could be likely…..
In the hope that you might be right the I would like to point out again that the appointment of Ms Clary announced just hours before te conference was not ( hopefully) a lucky coincidence.
I might be too optimistic but the following give me some sort of comfort:
”After completing her medical training, Dr Clary spent thirteen years working with Pfizer, Inc (NYSE: PFE) in New York, NY, where she rose to the position of Senior Vice President, US Medical.”
We wait.
Clean insights and information easily found, page-41
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.0¢ | $52.56K | 502.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 176914 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 217753 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |